Media

The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships.  Innovative programming around the current and future

Join fellow oncology professionals at the 2023 ASCO Annual Meeting – a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care. Join

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances

For the past 23 years, the World Vaccine Congress Washington has evolved and grown into the leading vaccines congress globally, with hundreds of speakers, thousands of attendees and hundreds of networking opportunities.   Our event

About Vaccines Summit Boston 2023 22-24 May, 2023 Following the tremendous response for Vaccines Summit Ohio 2021 and Vaccines Summit Boston 2022, Biogate Scientific Center brings to you the 3rd

ReMission Summit, March 25-26, 2023 WE’RE HERE TO REWRITE THE STORY OF BRAIN CANCER. LET’S EMPOWER PATIENTS TO TAKE THEIR LIVES BACK. It’s year four in our mission to lead

January 04, 2023 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy, announced today that

Vaccine exclusively delivered with the PharmaJet Stratis® Needle-free Injection System December 13, 2022 11:00 AM Eastern Standard Time   GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet®, a company that engineers precision delivery systems that overcome

November 08, 2022 08:30 AM Eastern Standard Time   ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held clinical-stage biotechnology company pioneering the development of LAMP-mediated nucleic acid-based immunotherapy, today announced

October 10, 2022 09:00 AM Eastern Daylight Time   ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy announced today

Brian Stamper, VP Cell Therapy Operations will participate in the Endpoints webinar titled “Overcoming Manufacturing Challenges for Advanced Medicines” on November 1st from 12-1pm EST. Click here to register: https://webinars.endpts.com/overcoming-manufacturing-challenges-for-advanced-medicines/

ITI will be attending The 41st Annual Health Care Conference that will take place on January 9-11, 2023 at the Westin St. Francis in San Francisco, CA. This premier conference